Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aardvark Therapeutics, Inc. | 10%+ Owner | Common Stock | 2.05M | Feb 14, 2025 | By Vickers Venture Fund VI Pte. Ltd. | ||
Vickers Vantage Corp. I | Other*, 10%+ Owner | Warrants | 901K | Nov 10, 2022 | By Vickers Venture Fund VI Pte Ltd | ||
Vickers Vantage Corp. I | Other*, 10%+ Owner | Warrants | 99K | Nov 10, 2022 | By Vickeres Venture Fund VI (Plan) Pte Ltd | ||
Aardvark Therapeutics, Inc. | 10%+ Owner | Series A Convertible Preferred Stock | 0 | Feb 14, 2025 | By Vickers Venture Fund VI Pte. Ltd. | ||
Aardvark Therapeutics, Inc. | 10%+ Owner | Series B Convertible Preferred Stock | 0 | Feb 14, 2025 | By Vickers Venture Fund VI Pte. Ltd. |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AARD | Aardvark Therapeutics, Inc. | Feb 14, 2025 | 4 | $0 | 4 | Feb 19, 2025 | 10%+ Owner |
AARD | Aardvark Therapeutics, Inc. | Feb 12, 2025 | 0 | $0 | 3 | Feb 12, 2025 | 10%+ Owner |
SCLX | Vickers Vantage Corp. I | Nov 10, 2022 | 2 | $0 | 4 | Nov 15, 2022 | Other*, 10%+ Owner |